StemCell Therapy

The 47 rating InvestorsObserver gives to Beam Therapeutics Inc (BEAM) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 41 percent of stocks in the Biotechnology industry, BEAMs 47 overall rating means the stock scores better than 47 percent of all stocks.

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 47 would rank higher than 47 percent of all stocks.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

Beam Therapeutics Inc (BEAM) stock is down -6.18% while the S&P 500 is up 1.19% as of 2:33 PM on Wednesday, Aug 12. BEAM has fallen -$1.46 from the previous closing price of $23.62 on volume of 519,613 shares. Over the past year the S&P 500 is up 0.83% while BEAM is up 18.19%. BEAM lost -$2.68 per share the over the last 12 months.

To screen for more stocks like BEAM click here.

View original post here:
Where Does Beam Therapeutics Inc (BEAM) Stock Fall in the Biotechnology Field? - InvestorsObserver

TEL AVIV, Israel, Aug. 12, 2020 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today reported financial and operating results for the second quarter ended June 30, 2020. The Company's six-month progress includes the development of several strategic initiatives, including growth-oriented opportunities in pain management and COVID-19 related therapeutics.

"Despite the COVID-19 pandemic business disruptions and the near-term delays to completing and commencing our clinical programs in Israel and the U.S., respectively, we acted swiftly over the past few months to leverage our sought-after technology to create several long-term business initiatives to enhance our value," commented Dr. Shai Yarkoni, Chief Executive Officer. "In addition to pursuing a potential merger with a global leader in the high growth medical-grade cannabis market, which is being delayed due to COVID-19, we have either initiated or are contemplating other business development activities that will greatly benefit from our innovation, technology and know-how. I believe each of these opportunities represents meaningful catalysts for Cellect in multi-billion-dollar markets, subject to resolution of the COVID-19 pandemic and return to normal course of business."

Notwithstanding the continued delays due to COVID-19, the Company remains focused on the following operational and clinical objectives:

The Company's cash and cash equivalents totaled $7 million as of June 30, 2020, which includes the approximately $1.5 million (gross before expenses)resulting from several investors exercising certain warrants that were issued in February 2019.

SecondQuarter 2020 Financial Results:

*For the convenience of the reader, the amounts above have been translated from NIS into U.S. dollars, at the representative rate of exchange on June 30, 2020 (U.S. $1 = NIS 3.466).

About Cellect Biotechnology Ltd.

Cellect Biotechnology (APOP) has developed a breakthrough technology, for the selection of stem cells from any given tissue, that aims to improve a variety of stem cell-based therapies.

The Company's technology is expected to provide researchers, clinical community and pharma companies with the tools to rapidly isolate stem cells in quantity and quality allowing stem cell-based treatments and procedures in a wide variety of applications in regenerative medicine. The Company's current clinical trial is aimed at bone marrow transplantations in cancer treatment.

Forward Looking Statements

This press release contains forward-looking statements about the Company's expectations, beliefs and intentions. Forward-looking statements can be identified by the use of forward-looking words such as "believe", "expect", "intend", "plan", "may", "should", "could", "might", "seek", "target", "will", "project", "forecast", "continue" or "anticipate" or their negatives or variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical matters. For example, forward-looking statements are used in this press release when we discuss Cellect's expectations regarding timing of the commencement of its planned U.S. clinical trial and its plan to reduce operating costs. These forward-looking statements and their implications are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In addition, historical results or conclusions from scientific research and clinical studies do not guarantee that future results would suggest similar conclusions or that historical results referred to herein would be interpreted similarly in light of additional research or otherwise. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: the Company's history of losses and needs for additional capital to fund its operations and its inability to obtain additional capital on acceptable terms, or at all; the Company's ability to continue as a going concern; uncertainties of cash flows and inability to meet working capital needs; the Company's ability to obtain regulatory approvals; the Company's ability to obtain favorable pre-clinical and clinical trial results; the Company's technology may not be validated and its methods may not be accepted by the scientific community; difficulties enrolling patients in the Company's clinical trials; the ability to timely source adequate supply of FasL; risks resulting from unforeseen side effects; the Company's ability to establish and maintain strategic partnerships and other corporate collaborations; the scope of protection the Company is able to establish and maintain for intellectual property rights and its ability to operate its business without infringing the intellectual property rights of others; competitive companies, technologies and the Company's industry; unforeseen scientific difficulties may develop with the Company's technology; the Company's ability to retain or attract key employees whose knowledge is essential to the development of its products; and the Company's ability to pursue any strategic transaction or that any transaction, if pursued, will be completed. Any forward-looking statement in this press release speaks only as of the date of this press release. The Company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws. More detailed information about the risks and uncertainties affecting the Company is contained under the heading "Risk Factors" in Cellect Biotechnology Ltd.'s Annual Report on Form 20-F for the fiscal year ended December 31, 2019 filed with the U.S. Securities and Exchange Commission, or SEC, which is available on the SEC's website, http://www.sec.gov, and in the Company's periodic filings with the SEC.

Cellect Biotechnology Ltd.

Consolidated Statement of Operation

Convenience

translation

Six months

ended

Six months ended

Three months ended

June 30,

June 30,

June 30,

2020

2020

2019

2020

2019

Unaudited

Unaudited

U.S. dollars

NIS

(In thousands, except share and per

share data)

Research and development expenses

837

2,901

7,086

1,364

3,564

General and administrative expenses

1,356

4,703

5,064

2,116

2,709

Operating loss

2,193

7,604

12,150

3,480

6,273

Financial expenses (income) due to warrants exercisable into shares

1,098

3,807

(7,111)

4,697

(5,919)

Other financial expenses (income), net

(15)

(55)

880

627

462

Total comprehensive loss

3,276

11,356

5,919

8,804

816

Loss per share:

Basic and diluted loss per share

0.010

0.034

0.029

0.024

0.004

Weighted average number of shares outstanding used to compute basic and diluted loss per share

338,182,275

338,182,275

200,942,871

365,428,101

224,087,799

Cellect Biotechnology Ltd.

Consolidated Balance Sheet Data

Convenience

translation

June 30,

June 30,

December 31,

2020

2020

2019

Unaudited

Unaudited

Audited

U.S. dollars

NIS

(In thousands, except share and per

share data)

CURRENT ASSETS:

Link:
Cellect Biotechnology Reports Second Quarter Financial and Operating Results; First Half 2020 Strategic Developments Create Long-Term Revenue...

In the latest report, Report Ocean has provided unique insights about the Biotechnology Market. This report provides in detail analysis of market with revenue growth and upcoming trends. Biotechnology Market research report derived key statistics, based on the market status of the manufacturers and is a valuable source of guidance and direction for companies and individuals interested in Biotechnology Market.

This research report offers in-depth study about Market Size and Share, Product and Services, Company Profile, Regional Forecast, Consumer Preference, Market Competition, and Industry Chain Structure.

This research report represents the statistical data in the form of TABLES, CHARTS, and infographics to assess the market, its growth and development, and market trends of the Biotechnology Market during the forecasted period.

COVID 19 Impact on Biotechnology Market

The Coronavirus Pandemic (COVID-19) has affected every aspect of life worldwide. Under COVID-19 Outbreak, how the Biotechnology Market Industry will develop is also analyzed in detail in Chapter 1.7 of the report.

In Chapter 2.4, we analyzed industry trends in the context of COVID-19.

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

Request Free Sample Report athttps://www.reportocean.com/industry-verticals/sample-request?report_id=mai31385

competitive landscape:

Key players in the global Biotechnology market covered in Chapter 4:DanaherF. Hoffmann-La RocheThermo Fisher ScientificAgilent TechnologiesMerckQiagenIlluminaPerkinElmerAmgenBio-Rad LaboratoriesBioGen Medical InstrumentsAbbott Laboratories

This report also outlines the Major companies or players involved in the Biotechnology Market industry, along with product specifications, revenue generated, pricing strategies, contact information, information related to raw materials, equipment and demands. With the help of tables and figures, valuable insights on production, value, price, and gross margin of each player are offered.

Market Segmentation:

The segmentation study is considered as the key section to decide the target market with keen study of segments or smaller sections such as geographical regions, application and product type to optimize advertising technique and marketing strategies at regional as well as global level of the Biotechnology Market.

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2020-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)

United States

Canada

Mexico

Europe (Covered in Chapter 7 and 13)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8 and 13)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 9 and 13)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 10 and 13)

Brazil

Argentina

Columbia

Chile

Others

Some of the Major Highlights of TOC covers:

Report Overview

Study Scope

Key Market Segments

Regulatory Scenario by Region/Country

Market Investment Scenario Strategic

Global Market Growth Trends

Industry Trends

SWOT Analysis

Porters Five Forces Analysis

Potential Market and Growth Potential Analysis

Industry News and Policies by Regions

Industry News

Industry Policies

Industry Trends Under COVID-19

Value Chain Biotechnology Market

Value Chain Status

Biotechnology Market Manufacturing Cost Structure Analysis

Production Process Analysis

Manufacturing Cost Structure of Biotechnology Market

Labor Cost of Biotechnology Market

Labor Cost of Biotechnology Market Under COVID-19

Sales and Marketing Model Analysis

Downstream Major Customer Analysis (by Region)

Value Chain Status Under COVID-19

Biotechnology Market Production, Revenue (Value), Price Trend by Type

Production and Market Share by Type

Revenue and Market Share by Type

Price by Type

Biotechnology Market Production, Consumption, Export, Import by Region

Production, Consumption, Export, Import by Region

Production, Consumption, Export, Import by Country

Production, Revenue, Price and Gross Margin

Industrial Chain, Sourcing Strategy and Downstream Buyers

Biotechnology Market Industrial Chain Analysis

Raw Materials Sources of Biotechnology Market major Players in 2019

Downstream Buyers

Biotechnology Market Forecast

Biotechnology Market Sales, Revenue and Growth Rate

Biotechnology Market Production, Consumption, Export and Import Forecast by Region

Biotechnology Market Production, Revenue and Price Forecast by Type

Biotechnology Market Consumption Forecast by Application

Biotechnology Market Forecast Under COVID-19

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2026

Inquire or Share Your Questions If Any before Purchasing This Report:https://www.reportocean.com/industry-verticals/sample-request?report_id=mai31385

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe, and Asia.

Link:
COVID-19 Impact on Biotechnology Market 2020 future development, manufacturers, trends, share, size and forecast edited by leading research firm -...

The 67 rating InvestorsObserver gives to Capricor Therapeutics Inc (CAPR) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 77 percent of stocks in the Biotechnology industry, CAPRs 67 overall rating means the stock scores better than 67 percent of all stocks.

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.

Capricor Therapeutics Inc (CAPR) stock has fallen -12.65% while the S&P 500 is higher by 1.27% as of 11:28 AM on Wednesday, Aug 12. CAPR is lower by -$0.85 from the previous closing price of $6.72 on volume of 1,273,064 shares. Over the past year the S&P 500 is up 15.37% while CAPR is higher by 96.98%. CAPR lost -$1.66 per share the over the last 12 months.

To see the top 5 stocks in Biotechnology click here.

Go here to read the rest:
Is Capricor Therapeutics Inc (CAPR) Stock Near the Top of the Biotechnology Industry? - InvestorsObserver

At the end of the latest market close, Unity Biotechnology Inc. (UBX) was valued at $11.98. In that particular session, Stock kicked-off at the price of $12.20 while reaching the peak value of $12.29 and lowest value recorded on the day was $11.31. The stock current value is $11.78.

Recently in News on August 4, 2020, UNITY Biotechnology Announces $80M Debt Financing From Hercules Capital. UNITY Biotechnology (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that it has entered into a $80 million debt facility with Hercules Capital [NYSE: HTGC]. You can read further details here

Unity Biotechnology Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the companys stock is recorded $15.44 on 08/10/20, with the lowest value was $4.62 for the same time period, recorded on 03/13/20.

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stocks existing status and the future performance. Presently, Unity Biotechnology Inc. shares are logging -23.70% during the 52-week period from high price, and 154.98% higher than the lowest price point for the same timeframe. The stocks price range for the 52-week period managed to maintain the performance between $4.62 and $15.44.

The companys shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1416746 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Unity Biotechnology Inc. (UBX) recorded performance in the market was 63.38%, having the revenues showcasing 70.48% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 626.46M, as it employees total of 100 workers.

During the last month, 0 analysts gave the Unity Biotechnology Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 7.76, with a change in the price was noted +6.65. In a similar fashion, Unity Biotechnology Inc. posted a movement of +129.63% for the period of last 100 days, recording 418,635 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the companys financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders equity The total Debt to Equity ratio for UBX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Raw Stochastic average of Unity Biotechnology Inc. in the period of last 50 days is set at 55.31%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 51.94%. In the last 20 days, the companys Stochastic %K was 63.33% and its Stochastic %D was recorded 74.31%.

If we look into the earlier routines of Unity Biotechnology Inc., multiple moving trends are noted. Year-to-date Price performance of the companys stock appears to be pessimistic, given the fact the metric is recording 63.38%. Additionally, trading for the stock in the period of the last six months notably improved by 83.20%, alongside a boost of 76.35% for the period of the last 12 months. The shares increased approximately by 15.15% in the 7-day charts and went down by 59.40% in the period of the last 30 days. Common stock shares were driven by 70.48% during last recorded quarter.

Go here to read the rest:
Unity Biotechnology Inc. (UBX) market price of $11.78 offers the impression of an exciting value play - The InvestChronicle

Industry Overview of Agriculture Biotechnology Market Report 2020

Market Expertz has published yet another new report on the global Agriculture Biotechnology market. This report can help the user to better understand the opportunities and threats that are doled by the industry and its players. Additionally, this study is inclusive of the market scenario and factors like the players who influence and dominate the industry. The strategies of these players, the products they offer, their operating areas, and the opportunities are discussed in detail. The report serves the analysis of the global market share, segmentation, revenue growth estimation, and geographic regions of the market.

The report includes the latest coverage of the impact of COVID-19 on the Agriculture Biotechnology industry. The incidence has affected nearly every aspect of the business domain. This study evaluates the current scenario and predicts future outcomes of the pandemic on the global economy.

To request for a free sample of the insightful Agriculture Biotechnology market report click [emailprotected] https://www.marketexpertz.com/sample-enquiry-form/88805

This study analyses the growth of Agriculture Biotechnology based on the present, past and futuristic data and will render entire information about the Agriculture Biotechnology industry to the market-leading industry players that will guide the direction of the Agriculture Biotechnology market through the forecast period. All of these players are analyzed in detail to get details concerning their recent announcements and partnerships, product/services, investment strategies, and so on.

Competitive Landscape:

Agriculture Biotechnology market report highlights key players included in the market in order to render a comprehensive view of the competing players existing in the market. Company details, strategies, aptitude, history, cost analysis, and prevalent strategies

Leading Agriculture Biotechnology manufacturers/companies operating at both regional and global levels:

ADAMA Agricultural SolutionsVilmorinBayerBiocentury TransgeneCertisDow AgroSciencesEurofinsEvogeneGlobal Bio-chem TechnologySyngentaKWS SaatMarina BiotechMonsantoOthers

The report also inspects the financial standing of the leading companies, which includes gross profit, revenue generation, sales volume, sales revenue, manufacturing cost, individual growth rate, and other financial ratios.

The Agriculture Biotechnology market report provides successfully marked contemplated policy changes, favorable circumstances, industry news, developments, and trends. The information is verified and validated through primary interviews and questionnaires. The data on growth and trends focuses on new technologies, market capacities, markets and materials, CAPEX cycle, and the dynamic structure of the Agriculture Biotechnology market.

!!! Limited Time DISCOUNT Available!!! Get Your Copy at Discounted [emailprotected] https://www.marketexpertz.com/discount-enquiry-form/88805

Industry outlook:

Agriculture Biotechnology product types, applications, geographies, and end-user industries are the key market segments that are comprised in this study. The report speculates the prospective growth of the different market segments by studying the current market standing, performance, demand, production, sales, and growth prospects existing in the market.

The segmentation included in the report is beneficial for readers to capitalize on the selection of appropriate segments for the Agriculture Biotechnology sector and can help companies in deciphering the optimum business move to reach their desired business goals.

In market segmentation by types of Agriculture Biotechnology, the report covers-

BiochipsDeoxy ribonucleic acid (DNS) sequencingGenome editing toolsRibonucleic acid interference (RNAI)Synthetic biologyOthers

In market segmentation by applications of the Agriculture Biotechnology, the report covers the following uses-

Transgenic crops marketSynthetic biology-enabled products marketOthers

This Agriculture Biotechnology report umbrellas vital elements such as market trends, share, size, and aspects that facilitate the growth of the companies operating in the market to help readers implement profitable strategies to boost the growth of their business. This report also analyses the expansion, market size, key segments, market share, application, key drivers, and restraints.

Click here to inquire about customization and available discounts on the [emailprotected] https://www.marketexpertz.com/customization-form/88805

Highlights of the Agriculture Biotechnology market study:

Speculations for sales:

The report contains historical revenue and volume that backing information about the market capacity, and it helps to evaluate conjecture numbers for key areas in the Agriculture Biotechnology market. Additionally, it includes a share of every segment of the Agriculture Biotechnology market, giving methodical information about types and applications of the market.

Key point summary of the Agriculture Biotechnology market report:

In the end, the Agriculture Biotechnology market is analyzed for revenue, sales, price, and gross margin.

Report customization:

Market Expertz also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.

Read the full Research Report along with a table of contents, facts and figures, charts, graphs, etc. @ https://www.marketexpertz.com/industry-overview/agriculture-biotechnology-market

Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

About Us:Planning to invest in market intelligence products or offerings on the web? Then marketexpertz has just the thing for you reports from over 500 prominent publishers and updates on our collection daily to empower companies and individuals catch-up with the vital insights on industries operating across different geography, trends, share, size and growth rate. Theres more to what we offer to our customers. With marketexpertz you have the choice to tap into the specialized services without any additional charges.

Contact Us:John WatsonHead of Business Development40 Wall St. 28th floor New York CityNY 10005 United StatesDirect Line: +1-800-819-3052Visit our News Site: http://newssucceed.com

David is an Experience Business writer who regularly contributes to the blog, He specializes in manufacturing news

Original post:
How Agriculture Biotechnology Market Will Dominate In Coming Years? Key Players: ADAMA Agricultural Solutions, Vilmorin, Bayer, Biocentury Transgene -...

The 29 rating InvestorsObserver gives to Tauriga Sciences Inc (TAUG) stock puts it near the bottom of the Biotechnology industry. In addition to scoring higher than 13 percent of stocks in the Biotechnology industry, TAUGs 29 overall rating means the stock scores better than 29 percent of all stocks.

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 29 means the stock is more attractive than 29 percent of stocks.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

Tauriga Sciences Inc (TAUG) stock is unmoved 5.4% while the S&P 500 has risen 0.52% as of 2:42 PM on Tuesday, Aug 11. TAUG is flat $0.00 from the previous closing price of $0.03 on volume of 935,630 shares. Over the past year the S&P 500 has risen 17.16% while TAUG is flat 0.00%. TAUG lost -$0.04 per share the over the last 12 months.

To see InvestorsObserver's Sentiment Score for Tauriga Sciences Inc click here.

View post:
Is Tauriga Sciences Inc (TAUG) The Right Choice in Biotechnology? - InvestorsObserver

It is our aim to provide our readers with report for Pharmaceuticals and Biotechnology R&D Market, which examines the industry during the period 2020 2026. One goal is to present deeper insight into this line of business in this document. The first part of the report focuses on providing the industry definition for the product or service under focus in the Pharmaceuticals and Biotechnology R&D Market report. Next, the document will study the factors responsible for hindering and enhancing growth in the industry. After covering various areas of interest in the industry, the report aims to provide how the Pharmaceuticals and Biotechnology R&D Market will grow during the forecast period.

The major vendors covered:

ROCHE, JOHNSON & JOHNSON, MERCK, NOVARTIS, PFIZER, SANOFI, BAYER, BRISTOL-MYERS SQUIBB, ASTRAZENECA, GLAXOSMITHKLINE, ABBVIE, ELI LILLY, BOEHRINGER SOHN, AMGEN, GILEAD SCIENCES, TAKEDA PHARMACEUTICAL, NOVO NORDISK, BIOGEN, ABBOTT, ASTELLAS PHARMA, TEVA PHARMACEUTICAL INDUSTRIES and more

The final report will add the analysis of the Impact of Covid-19 on Pharmaceuticals and Biotechnology R&D Market.

Request a sample copy @ https://www.reportsandmarkets.com/sample-request/global-pharmaceuticals-and-biotechnology-r-d-market-size-status-and-forecast-2020-2026?utm_source=bulletinline&utm_medium=38

The Pharmaceuticals and Biotechnology R&D Market report between the years 2020 2026 will highlight the current value of the industry. At the same time, there is also an estimate of how much this line of business will be worth at the end of the forecast period. As it is our goal to maintain high levels of accuracy at all times, we will take a look at the CAGR of the Pharmaceuticals and Biotechnology R&D Market. We make sure that all the information available in this report has excellent levels of readability. One way we achieve this target is by Pharmaceuticals and Biotechnology R&D Market segmentation. Going through the report for 2020 2026 will bring our readers up-to-date regarding this industry.

While examining the information from this document, one thing becomes clear, the elements which contribute to increase in demand for the product or service. At the same time, there will be a focus on what drives the popularity of these types of products or services. This report is for those who want to learn about Pharmaceuticals and Biotechnology R&D Market, along with its forecast for 2020 2026. Information regarding market revenue, competitive partners, and key players will also be available.

Segmentation

As discussed earlier, there is segmentation in the Pharmaceuticals and Biotechnology R&D Market report, to improve the accuracy and make it easier to collect data. The categories which are the dividing factors in the industry are distribution channels, application, and product or service type. With this level of segmentation, it becomes easier to analyze and understand the Pharmaceuticals and Biotechnology R&D Market. At the same time, there is emphasis on which type of consumers become the customers in this industry. When it comes to distribution channels, the Pharmaceuticals and Biotechnology R&D Market report looks at the different techniques of circulation of the product or service.

Regional Overview

In this part of the Pharmaceuticals and Biotechnology R&D Market report, we will be taking a look at the geographical areas and the role they play in contributing to the growth of this line of business. The areas of interest in this document are as follows Middle East and Africa, South and North America, Europe, and Asia Pacific. From the Pharmaceuticals and Biotechnology R&D Market report, it becomes clear which region is the largest contributor.

Latest Industry News

From this Pharmaceuticals and Biotechnology R&D Market report, the reader will also get to learn about the latest developments in the industry. The reason is that these products or services have the potential to disrupt this line of business. If there is information about company acquisitions or mergers, this information will also be available in this portion of the Pharmaceuticals and Biotechnology R&D Market report.

If you have any special requirements about this Pharmaceuticals and Biotechnology R&D Market report, please let us know and we can provide custom report.

Inquire more about this report @ https://www.reportsandmarkets.com/enquiry/global-pharmaceuticals-and-biotechnology-r-d-market-size-status-and-forecast-2020-2026?utm_source=bulletinline&utm_medium=38

About Us

ReportsAndMarkets.com allocates the globally available market research and many company reports from reputed market research companies that are a pioneer in their respective domains. We are completely an autonomous group and serve our clients by offering the trustworthy available research stuff, as we know this is an essential aspect of Market Research.

Contact Us

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

Originally posted here:
Pharmaceuticals and Biotechnology R&D Market Growth, Statistics, By Application, Production, Revenue & Forecast To 2026 - Bulletin Line

Vir Biotechnology, Inc. (NASDAQ:VIR) went down by -1.02% from its latest closing price when compared to the 1-year high value of $75.00 and move down -42.42%, while VIR stocks collected 4.07% of gains with the last five trading sessions. Press Release reported 8 hours ago that Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2020 Financial Results

Vir Biotechnology, Inc. (NASDAQ:VIR) 2 of the analysts out of 5 who provided ratings for Vir Biotechnology, Inc. stocks as a buy while 0 as overweight, 1 rated it as hold and 1 as sell. The average price we get from analysts is $32.50 which is -$17.99 below current price. VIR currently has a short float of 3.28% and public float of 106.55M with average trading volume of 1.47M shares.

VIR stocks went up by 4.07% for the week, with the monthly jump of 4.86% and a quarterly performance of 74.03%. The simple moving average for the period of the last 20 days is 5.77% for VIR stocks with the simple moving average of 82.96% for the last 200 days.

Many brokerage firms have already submitted their reports for VIR stocks, with JP Morgan repeating the rating for VIR shares by setting it to Underweight. The predicted price for VIR socks in the upcoming period according to JP Morgan is $26 based on the research report published on March 19, 2020.

Goldman, on the other hand, stated in their research note that they expect to see VIR stock at the price of $26. The rating they have provided for VIR stocks is Neutral according to the report published on March 13, 2020.

Robert W. Baird gave Underperform rating to VIR stocks, setting the target price at $17 in the report published on February 27, 2020.

After a stumble in the market that brought VIR to its low price for the period of the last 52 weeks, Vir Biotechnology, Inc. was unable to take a rebound, for now settling with -29.79% of loss for the given period.

The stock volatility was left at 6.16%, however, within the period of a single month, the volatility rate increased by 6.47%, while the shares surge at the distance of +6.21% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +48.97% upper at the present time.

In the course of the last 5 trading sessions, VIR went up by +4.07%, which changed the moving average for the period of 200 days to the total of +268.25% of gains for the stock in comparison to the 20-day moving average settled at $49.94. In addition, Vir Biotechnology, Inc. saw 318.77% in overturn over the period of a single year with a tendency to cut further gains.

Reports are indicating that there were more than several insider trading activities at Vir Biotechnology, Inc. (VIR), starting from Pang Phillip, who sold 12,500 shares at the price of $50.90 back on Aug 05. After this action, Rushing now owns 15,777 shares of Vir Biotechnology, Inc., valued at $636,222 with the latest closing price.

Pang Phillip, the Chief Medical Officer of Vir Biotechnology, Inc., sold 12,500 shares at the value of $50.90 during a trade that took place back on Aug 05, which means that Pang Phillip is holding 15,777 shares at the value of $636,222 based on the most recent closing price.

The current profitability levels are settled at -2144.35 for the present operating margin. The net margin for Vir Biotechnology, Inc. stands at -2158.98. Total capital return value is set at -62.52, while invested capital returns managed to touch -62.97.

Based on Vir Biotechnology, Inc. (VIR), the companys capital structure generated 0.27 points for debt to equity in total, while total debt to capital is set at the value of 0.27.

Read the original here:
Is a Correction Looming Ahead? Vir Biotechnology, Inc. (VIR) - The News Heater

The PDS Biotechnology Corporation (PDSB) shares are trading at lower $3.00 and the avg recommendation for the stock is Moderate Buy. while the current analyst price target stands at $6.48.

To add more color to this target, the companys high over the last year is $6.51 and the low is $0.62. Over the last 52 weeks, PDSB is down -53.92% while the S&P 500 is down -0.83%. The catalyst for this interesting swing was the companys recent earnings report.

A Notable Earnings Report

PDSB Return on Equity (ROE) is -105.10%, and its Return on Assets is -85.20%. All told, it is clear that, PDSB needs to be on your watchlist.

Find out when PDSB reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. PDSB has a short ratio of 0.37 and outstanding shares of 10.32M.

Company Outlook

PDSB has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 1.39 million and more growth is possible in the weeks ahead. Traders will also note the companys earnings per share came in at -3.02. PDS Biotechnology Corporation PDSB also noted assets of $23.93 million at the end of the last quarter. Investors should also keep an eye on sector updates as PDSB has historically followed its peers on positive news.

All told, PDS Biotechnology Corporation PDSB has strung together solid data and demonstrated underlying fundamentals. At its current valuation, PDSB represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

PDS Biotechnology Corporation PDSB is now commanding a market cap of 45.33M and a float of 9.77M. PDSB is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of PDSB stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in PDSB, either long or short, and we have not been compensated for this article.

Post Views: 60

Read this article:
The Rejuvenation of PDS Biotechnology Corporation (NASDAQ:PDSB) - The Oracle Dispatch

Next-Generation Biomanufacturing Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail. Well explained SWOT analysis, revenue share and contact information are shared in this report analysis. It also provides market information in terms of development and its capacities.

Next-Generation Biomanufacturing Market is growing at a High CAGR during the forecast period 2020-2026. The increasing interest of the individuals in this industry is that the major reason for the expansion of this market.

Get Sample Copy (Including FULL TOC, Graphs and Tables) of this report @:

https://www.a2zmarketresearch.com/sample?reportId=280469

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Top Key Players Profiled in This Report:

Applikon Biotechnology BV, bbi-biotech GmbH, Danaher Corporation, Eppendorf AG, Esco Group of Companies, GEA Group Aktiengesellschaft, Meissner Filtration Products, Inc., Merck KGaA, PBS Biotech, Inc., Pierre Gurin, Sartorius AG, Shanghai Bailun Biotechnology Co. Ltd., Solaris Biotechnology Srl., Thermo Fisher Scientific Inc., ZETA GmbH

The key questions answered in this report:

Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Next-Generation Biomanufacturing market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Next-Generation Biomanufacturing markets trajectory between forecast periods.

Buy Exclusive Report with Attractive Discount @:

https://www.a2zmarketresearch.com/discount?reportId=280469

Reasons for buying this report:

Table of Contents

Global Next-Generation Biomanufacturing Market Research Report 2020 2026

Chapter 1 Next-Generation Biomanufacturing Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Next-Generation Biomanufacturing Market Forecast

If You Have Any Query, Ask Our Experts:

https://www.a2zmarketresearch.com/enquiry?reportId=280469

If you have any special requirements, please let us know and we will offer you the report as you want.

Link:
Next-Generation Biomanufacturing Market will touch a new level in upcoming year with Top Key Players like Applikon Biotechnology BV, bbi-biotech GmbH,...

Global Pharmaceutical & Biotechnology Environmental Monitoring Market: Competitive Analysis

Market Data Analyticshas published a new report on the globalPharmaceutical & Biotechnology Environmental Monitoring market. This new report includes all the details about the Pharmaceutical & Biotechnology Environmental Monitoring market; it particularly includes the effect of COVID-19 on the Pharmaceutical & Biotechnology Environmental Monitoring market.

The report study begins with the Pharmaceutical & Biotechnology Environmental Monitoring market definition and scope. Next there is a brief discussion about the target audience of the market. In the subjective part of the Pharmaceutical & Biotechnology Environmental Monitoring report study, the growth factors and the limitation are included. The impact of the pandemic has affected all the markets on the global platform and thus the market drivers and limitations have changed ever sinceCOVID-19has struck. Similarly, the Pharmaceutical & Biotechnology Environmental Monitoring market opportunities and challenges has also changed drastically owing to the changing market scenario, economic crisis faced by several countries, and the changed trading scenario.

Request a sample copy of this report@https://www.marketdataanalytics.biz/worldwide-pharmaceutical-biotechnology-environmental-monitoring-market-report-2020-industry-39498.html#request-sample

In the next section, there is descriptive information about the market segmentation. The segments of the Pharmaceutical & Biotechnology Environmental Monitoring market that are discussed includes{Monitoring Equipment, Media, Software, Microbiology Services};{Pharmaceutical Industry, Biotechnology Industry, Academic & Research Institutes}. Along with these major segments, the sub-segments of the Pharmaceutical & Biotechnology Environmental Monitoring market is also included in the dossier. Every single aspect of each segment is discussed by providing proper statistical data and qualitative explanation. The statistical data was obtained through thorough research and analysis by the research analyst. The qualitative data that is obtained is a result of several primary and secondary researches. The market demand and size are obtained by the research analysts and are further validated with the market experts. The geographical presence of the Pharmaceutical & Biotechnology Environmental Monitoring market is also studied in depth. The major regions that are included within the study include North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa.

Read Full Research Report::https://www.marketdataanalytics.biz/worldwide-pharmaceutical-biotechnology-environmental-monitoring-market-report-2020-industry-39498.html

In the later part of the study, all the market players that are operating in the Pharmaceutical & Biotechnology Environmental Monitoring market is included. Detailed profiling of each and every company is done for better understanding the market strategies implemented by these players to retain their competitiveness in the global platform. The major market players that are operating in the Pharmaceutical & Biotechnology Environmental Monitoring market areDanaher Corporation, Thermo Fisher Scientific, Merck KGaA, Eurofins Sinensis, Lonza, Biomerieux, VAI, Cosasco, RMONI, Amphenol Advanced Sensors, Vaisala. All these market players are profiled in the Pharmaceutical & Biotechnology Environmental Monitoring market report.

Benefits of Buying this Market Research Report

1.Analyst advocacy:Get correct answers of your queries from our analysts team of experts before and after purchasing the report.2.Meet Customers Requirements:Our expert team will assist with all your research requirements and customize the report.3.Unique Expertise:We centre around the quality standards and reliability of the report.4.One of a kind Expertise:Experts will give splendid bits of knowledge about the report.

If Any Inquiry of Pharmaceutical & Biotechnology Environmental Monitoring Report:https://www.marketdataanalytics.biz/worldwide-pharmaceutical-biotechnology-environmental-monitoring-market-report-2020-industry-39498.html#inquiry-for-buying

Continued here:
Global Pharmaceutical & Biotechnology Environmental Monitoring Market 2020 with Coronavirus (COVID-19) Impact Analysis | likewise Industry is...

The Global Separation Systems for Commercial Biotechnology market gives detailed Evaluation about all the Important aspects related to the marketplace. The analysis on global Separation Systems for Commercial Biotechnology economy, offers profound insights regarding the Separation Systems for Commercial Biotechnology market covering all of the crucial aspects of the market. Moreover, the report offers historical information with future prediction over the forecast period. Various important factors such as market trends, earnings growth patterns market shares and demand and supply are contained in almost all the market research report for every industry. A number of the vital facets analysed in the report contains market share, production, key regions, earnings rate in addition to key players.

The study of various segments of the global market are also Covered in the study report. In addition to that, for the prediction periods determination of variables such as market size and the competitive landscape of this sector is analysed in the report. On account of the rising globalization and digitization, there are new tendencies coming to the marketplace daily. The study report provides the in-depth analysis of all these tendencies.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2631240&source=atm

In addition, the Separation Systems for Commercial Biotechnology market report also provides the Latest trends in the Global Separation Systems for Commercial Biotechnology marketplace with the help of primary as well as secondary research methods. Additionally, the research report on Separation Systems for Commercial Biotechnology market provides a wide analysis of the market including market overview, production, producers, dimensions, price, value, growth rate, earnings, prices, export, consumption, and sales revenue of this Global Separation Systems for Commercial Biotechnology market. On the flip side, the Separation Systems for Commercial Biotechnology market report also studies the industry status for the prediction period. However, this can help to grow the advertising opportunities throughout the world in addition to major market suppliers.

Market Segment AnalysisThe research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.Segment by TypeMicroarrayLab-on-a-chipBiochipMagnetic separationChromatographyFlow cytometryMembrane filtrationElectrophoresisCentrifugation

Segment by ApplicationPharmaceuticalFood & CosmeticsAgricultureOthers

Global Separation Systems for Commercial Biotechnology Market: Regional AnalysisThe report offers in-depth assessment of the growth and other aspects of the Separation Systems for Commercial Biotechnology market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.Global Separation Systems for Commercial Biotechnology Market: Competitive LandscapeThis section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.The major players in the market include Thermo Fisher Scientific, GE Healthcare, Agilent Technologies;Shimadzu Corporation, bioMrieux SA, Bio-Rad Laboratories, Inc., Hitachi Koki, Merck &, Inc., QIAGEN, WATERS, Sartorius, PerkinElmer, Inc., Danaher, Miltenyi Biotec, BD, etc.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2631240&source=atm

The Separation Systems for Commercial Biotechnology market report provides useful insights for Every established and advanced players across the world. Furthermore the Separation Systems for Commercial Biotechnology market report provides accurate analysis for the shifting competitive dynamics. This study report comprises a complete analysis of future expansion concerning the evaluation of the mentioned prediction interval. The Separation Systems for Commercial Biotechnology market report provides a thorough study of the technological growth outlook over time to be aware of the market growth rates. The Separation Systems for Commercial Biotechnology marketplace report also has innovative analysis of the huge number of unique factors that are boosting or functioning as well as regulating the Separation Systems for Commercial Biotechnology marketplace growth.

A systematized methodology can be utilized to make a Report on the Global Separation Systems for Commercial Biotechnology market. For the research of market on the terms of research Approaches, these techniques are useful. All of the Information Regarding the Products, manufacturers, vendors, clients and much more is covered in research reports. Various important factors like market trends, revenue Growth patterns market stocks and supply and demand are included in virtually all The market study report for every business. Adaptation of fresh ideas and Accepting the latest tendencies are a few the reasons for any markets growth. The Global Separation Systems for Commercial Biotechnology market research report gives the deep understanding concerning the Regions where the market is impactful.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2631240&licType=S&source=atm

Read more from the original source:
Separation Systems for Commercial Biotechnology Market is Seeing Explosive Growth By Future Industry Winners: Forecast, 2014-2024 - Cole of Duty

The market research is a brilliant, complete, and much-needed resource for companies, stakeholders, and investors interested in the global Aptamers market. It informs readers about key trends and opportunities in the global Aptamers market along with critical market dynamics expected to impact the global market growth. It offers a range of market analysis studies, including production and consumption, sales, industry value chain, competitive landscape, regional growth, and price. On the whole, it comes out as an intelligent resource that companies can use to gain a competitive advantage in the global Aptamers market.

Key companies operating in the global Aptamers market include , TriLink BioTechnologies, AptaBharat, SomaLogic, AM Biotechnologies, Aptamer Sciences, Base Pair Biotechnologies, Aptamer Group, Aptagen, Aptus Biotech, NeoVentures Biotechnology, Ray Biotech, Vivonics

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1436031/global-aptamers-market

Segmental Analysis

Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global Aptamers market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.

Global Aptamers Market Segment By Type:

, DNA-Based Aptamers, RNA-Based Aptamers

Global Aptamers Market Segment By Application:

, Research and Development, Drug Discovery

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Aptamers market.

Key companies operating in the global Aptamers market include , TriLink BioTechnologies, AptaBharat, SomaLogic, AM Biotechnologies, Aptamer Sciences, Base Pair Biotechnologies, Aptamer Group, Aptagen, Aptus Biotech, NeoVentures Biotechnology, Ray Biotech, Vivonics

Key questions answered in the report:

For Discount, Customization in the Report: https://www.qyresearch.com/customize-request/form/1436031/global-aptamers-market

TOC

Table of Contents 1 Aptamers Market Overview1.1 Product Overview and Scope of Aptamers1.2 Aptamers Segment by Type 1.2.1 Global Aptamers Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 DNA-Based Aptamers 1.2.3 RNA-Based Aptamers1.3 Aptamers Segment by Application 1.3.1 Aptamers Sales Comparison by Application: 2020 VS 2026 1.3.2 Research and Development 1.3.3 Drug Discovery1.4 Global Aptamers Market Size Estimates and Forecasts 1.4.1 Global Aptamers Revenue 2015-2026 1.4.2 Global Aptamers Sales 2015-2026 1.4.3 Aptamers Market Size by Region: 2020 Versus 2026 2 Global Aptamers Market Competition by Manufacturers2.1 Global Aptamers Sales Market Share by Manufacturers (2015-2020)2.2 Global Aptamers Revenue Share by Manufacturers (2015-2020)2.3 Global Aptamers Average Price by Manufacturers (2015-2020)2.4 Manufacturers Aptamers Manufacturing Sites, Area Served, Product Type2.5 Aptamers Market Competitive Situation and Trends 2.5.1 Aptamers Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)2.6 Manufacturers Mergers & Acquisitions, Expansion Plans2.7 Primary Interviews with Key Aptamers Players (Opinion Leaders) 3 Aptamers Retrospective Market Scenario by Region3.1 Global Aptamers Retrospective Market Scenario in Sales by Region: 2015-20203.2 Global Aptamers Retrospective Market Scenario in Revenue by Region: 2015-20203.3 North America Aptamers Market Facts & Figures by Country 3.3.1 North America Aptamers Sales by Country 3.3.2 North America Aptamers Sales by Country 3.3.3 U.S. 3.3.4 Canada3.4 Europe Aptamers Market Facts & Figures by Country 3.4.1 Europe Aptamers Sales by Country 3.4.2 Europe Aptamers Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia3.5 Asia Pacific Aptamers Market Facts & Figures by Region 3.5.1 Asia Pacific Aptamers Sales by Region 3.5.2 Asia Pacific Aptamers Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam3.6 Latin America Aptamers Market Facts & Figures by Country 3.6.1 Latin America Aptamers Sales by Country 3.6.2 Latin America Aptamers Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina3.7 Middle East and Africa Aptamers Market Facts & Figures by Country 3.7.1 Middle East and Africa Aptamers Sales by Country 3.7.2 Middle East and Africa Aptamers Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Aptamers Historic Market Analysis by Type4.1 Global Aptamers Sales Market Share by Type (2015-2020)4.2 Global Aptamers Revenue Market Share by Type (2015-2020)4.3 Global Aptamers Price Market Share by Type (2015-2020)4.4 Global Aptamers Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Aptamers Historic Market Analysis by Application5.1 Global Aptamers Sales Market Share by Application (2015-2020)5.2 Global Aptamers Revenue Market Share by Application (2015-2020)5.3 Global Aptamers Price by Application (2015-2020) 6 Company Profiles and Key Figures in Aptamers Business6.1 TriLink BioTechnologies 6.1.1 Corporation Information 6.1.2 TriLink BioTechnologies Description, Business Overview and Total Revenue 6.1.3 TriLink BioTechnologies Aptamers Sales, Revenue and Gross Margin (2015-2020) 6.1.4 TriLink BioTechnologies Products Offered 6.1.5 TriLink BioTechnologies Recent Development6.2 AptaBharat 6.2.1 AptaBharat Aptamers Production Sites and Area Served 6.2.2 AptaBharat Description, Business Overview and Total Revenue 6.2.3 AptaBharat Aptamers Sales, Revenue and Gross Margin (2015-2020) 6.2.4 AptaBharat Products Offered 6.2.5 AptaBharat Recent Development6.3 SomaLogic 6.3.1 SomaLogic Aptamers Production Sites and Area Served 6.3.2 SomaLogic Description, Business Overview and Total Revenue 6.3.3 SomaLogic Aptamers Sales, Revenue and Gross Margin (2015-2020) 6.3.4 SomaLogic Products Offered 6.3.5 SomaLogic Recent Development6.4 AM Biotechnologies 6.4.1 AM Biotechnologies Aptamers Production Sites and Area Served 6.4.2 AM Biotechnologies Description, Business Overview and Total Revenue 6.4.3 AM Biotechnologies Aptamers Sales, Revenue and Gross Margin (2015-2020) 6.4.4 AM Biotechnologies Products Offered 6.4.5 AM Biotechnologies Recent Development6.5 Aptamer Sciences 6.5.1 Aptamer Sciences Aptamers Production Sites and Area Served 6.5.2 Aptamer Sciences Description, Business Overview and Total Revenue 6.5.3 Aptamer Sciences Aptamers Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Aptamer Sciences Products Offered 6.5.5 Aptamer Sciences Recent Development6.6 Base Pair Biotechnologies 6.6.1 Base Pair Biotechnologies Aptamers Production Sites and Area Served 6.6.2 Base Pair Biotechnologies Description, Business Overview and Total Revenue 6.6.3 Base Pair Biotechnologies Aptamers Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Base Pair Biotechnologies Products Offered 6.6.5 Base Pair Biotechnologies Recent Development6.7 Aptamer Group 6.6.1 Aptamer Group Aptamers Production Sites and Area Served 6.6.2 Aptamer Group Description, Business Overview and Total Revenue 6.6.3 Aptamer Group Aptamers Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Aptamer Group Products Offered 6.7.5 Aptamer Group Recent Development6.8 Aptagen 6.8.1 Aptagen Aptamers Production Sites and Area Served 6.8.2 Aptagen Description, Business Overview and Total Revenue 6.8.3 Aptagen Aptamers Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Aptagen Products Offered 6.8.5 Aptagen Recent Development6.9 Aptus Biotech 6.9.1 Aptus Biotech Aptamers Production Sites and Area Served 6.9.2 Aptus Biotech Description, Business Overview and Total Revenue 6.9.3 Aptus Biotech Aptamers Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Aptus Biotech Products Offered 6.9.5 Aptus Biotech Recent Development6.10 NeoVentures Biotechnology 6.10.1 NeoVentures Biotechnology Aptamers Production Sites and Area Served 6.10.2 NeoVentures Biotechnology Description, Business Overview and Total Revenue 6.10.3 NeoVentures Biotechnology Aptamers Sales, Revenue and Gross Margin (2015-2020) 6.10.4 NeoVentures Biotechnology Products Offered 6.10.5 NeoVentures Biotechnology Recent Development6.11 Ray Biotech 6.11.1 Ray Biotech Aptamers Production Sites and Area Served 6.11.2 Ray Biotech Aptamers Description, Business Overview and Total Revenue 6.11.3 Ray Biotech Aptamers Sales, Revenue and Gross Margin (2015-2020) 6.11.4 Ray Biotech Products Offered 6.11.5 Ray Biotech Recent Development6.12 Vivonics 6.12.1 Vivonics Aptamers Production Sites and Area Served 6.12.2 Vivonics Aptamers Description, Business Overview and Total Revenue 6.12.3 Vivonics Aptamers Sales, Revenue and Gross Margin (2015-2020) 6.12.4 Vivonics Products Offered 6.12.5 Vivonics Recent Development 7 Aptamers Manufacturing Cost Analysis7.1 Aptamers Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials7.2 Proportion of Manufacturing Cost Structure7.3 Manufacturing Process Analysis of Aptamers7.4 Aptamers Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers8.1 Marketing Channel8.2 Aptamers Distributors List8.3 Aptamers Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porters Five Forces Analysis 10 Global Market Forecast10.1 Global Aptamers Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Aptamers by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Aptamers by Type (2021-2026)10.2 Aptamers Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Aptamers by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Aptamers by Application (2021-2026)10.3 Aptamers Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Aptamers by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Aptamers by Region (2021-2026)10.4 North America Aptamers Estimates and Projections (2021-2026)10.5 Europe Aptamers Estimates and Projections (2021-2026)10.6 Asia Pacific Aptamers Estimates and Projections (2021-2026)10.7 Latin America Aptamers Estimates and Projections (2021-2026)10.8 Middle East and Africa Aptamers Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Read more:
New Report: Aptamers Market 2020- Analysis And In-Depth Research On Market Size, Trends, Emerging Growth Factors And Forecast To 2026| Celltrion,...

In the Neurofibromatoses Type II Therapecutics statistical surveying study, 2019 is considered as the base year, and 2020-2027 is considered as the estimate time frame to anticipate the market size. Significant districts stressed in the report incorporate North America, South America, Europe, Asia, Pacific region Middle East & Africa

The report on the Neurofibromatoses Type II Therapecutics Market gives a foot perspective on the present continuing inside the Neurofibromatoses Type II Therapecutics market. Further, the report likewise considers the effect of the novel COVID-19 pandemic on the Neurofibromatoses Type II Therapecutics market and offers an away from of the anticipated market variances during the estimate time frame.

The global Neurofibromatoses Type II Therapecutics market report covers major market players such as

Arno Therapeutics IncAstraZeneca PlcBeta Pharma IncLixte Biotechnology Holdings IncPlex Pharmaceuticals IncRecursion Pharmaceuticals Inc

Get Free Sample PDF (including full TOC, Tables and Figures) of Neurofibromatoses Type II Therapecutics Market @ https://www.glamresearch.com/report/global-neurofibromatoses-type-ii-therapecutics-market-by-product-309603/#sample

In 2027, the Neurofibromatoses Type II Therapecutics market is spectated to outperform ~US$ xx Mn/Bn with a CAGR of xx% over the estimate time frame. The Neurofibromatoses Type II Therapecutics market clicked an estimation of ~US$ xx Mn/Bn in 2019. Region is required to represent a critical piece of the overall industry, where the Neurofibromatoses Type II Therapecutics market size is anticipated to blow up with a CAGR of xx% during the estimate time frame.

The report inspects each Neurofibromatoses Type II Therapecutics market player as per its piece of the pie, creation impression, and development rate. SWOT examination of the players (qualities, weaknesses, opportunities and threats) has been covered in this report. Further, the Neurofibromatoses Type II Therapecutics market study portrays the ongoing dispatches, understandings, R&D undertakings, and business systems of the market players including.

High Points of the Global Neurofibromatoses Type II Therapecutics Report:

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2027.

Global Neurofibromatoses Type II Therapecutics Market Segmentation By Type:

AR-42FRAX-597Icotinib HydrochlorideLB-201LB-205Others

Global Neurofibromatoses Type II Therapecutics Market Segmentation By Applications:

ClinicHospitalHome Care

Place Inquiry for Buying or Customization of Report: https://www.glamresearch.com/report/global-neurofibromatoses-type-ii-therapecutics-market-by-product-309603/#inquiry

Global Neurofibromatoses Type II Therapecutics Market: Regional Analysis

The Neurofibromatoses Type II Therapecutics market is examined and showcase size data is given by region. The report incorporates nation astute and region-wise market size for the period 2015-2027. It additionally incorporates showcase size and conjecture by Type and by Application fragment as far as deals and income for the period 2015-2027.

The key regions covered in the Neurofibromatoses Type II Therapecutics market report are:

The examination report on the global Neurofibromatoses Type II Therapecutics market offers a treasury of economic situations and strategies wherein the market has been acting in various circumstances. Additionally, SWOT investigation and Porters Five Forces examination are utilized to speak to the positive and negative factors that are affecting the market development. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Global Neurofibromatoses Type II Therapecutics Market: Competitive Analysis

This area of the report recognizes different key makers of the market. It enables the reader to comprehend the systems and coordinated efforts that players are concentrating on battle rivalry in the market. The extensive report gives a critical infinitesimal gander at the market. The reader can distinguish the impressions of the producers by thinking about the worldwide income of makers, the worldwide cost of manufacturer, and deals by makers during the conjecture time of 2015 to 2027.

View original post here:
Global Neurofibromatoses Type II Therapecutics Market 2020 Impact of COVID-19, Future Growth Analysis and Challenges | Arno Therapeutics Inc,...

Paris, July 9, 2020 Atos, a global leader in digital transformation, announce that the Biocomputing Unit at the Spanish National Center for Biotechnology (CNB), part of the Spanish National Research Council (CSIC), is using Atos supercomputing resource to produce a refined 3D model of the SARS-Cov2 spike protein. By knowing more detail about the structure of this protein, which is the one that the virus uses to enter human cells, researchers can better understand how the virus initiates infection. This important step forward may help in the development of a vaccine.

The model, created at the Biocomputing Unit of CNB-CSIC using 3D cryoelectron microscopy, a complicated structural technique, will enable researchers and scientists to visualize not only the spike glycoprotein but also other SARS-Cov2 proteins. It has been made available to all scientific researchers across the world working on the virus.

Professor JM Carazo of CNB, said: Were really proud that we have been able to make this important step forward in the structural understanding of the viral glycoprotein, which is due in part to the acceleration provided by our powerful supercomputers. Now the scientific community worldwide can access a mass of structural knowledge around SARS-Cov-2, so we can work together to help make this invisible enemy visible.

Dr Natalia Jimenez, Atos HPC, AI and Quantum Life Sciences Center of Excellence Director added: Were honored to be able to provide these researchers the exceptional computing power needed to help them get results faster. By combining research expertise with our technological expertise and experience, were able to develop valuable resources that will help support the global fight against the virus.

The HPC resource includes Atos BullSequana X supercomputer, based at the CNB-CSIC in Madrid, plus additional compute capabilities and access to Atos experts at Atos new global HPC, AI & Quantum Life Sciences Center of Excellence. CNB-CSIC is one of the first research institutes to use this new center, which provides researchers with access to leading-edge technologies, such as Quantum, High Performance Computing and AI, supported by Atos products, services and expertise in these sectors to help boost Life Sciences discovery and innovation.

***

About Atos

Atos is a global leader in digital transformation with 110,000 employees in 73 countries and annual revenue of 12 billion. European number one in Cloud, Cybersecurity and High-Performance Computing, the Group provides end-to-end Orchestrated Hybrid Cloud, Big Data, Business Applications and Digital Workplace solutions. The Group is the Worldwide Information Technology Partner for the Olympic & Paralympic Games and operates under the brands Atos, Atos|Syntel, and Unify. Atos is a SE (Societas Europaea), listed on the CAC40 Paris stock index.

The purpose of Atos is to help design the future of the information space. Its expertise and services support the development of knowledge, education and research in a multicultural approach and contribute to the development of scientific and technological excellence. Across the world, the Group enables its customers and employees, and members of societies at large to live, work and develop sustainably, in a safe and secure information space.

Press contact:Laura Fau | laura.fau@atos.net | +33 6 73 64 04 18 | @laurajanefau

Follow this link:
Spanish National Center for Biotechnology uses Atos supercomputing expertise to find out how Covid-19 virus initiates infection - GlobeNewswire

The National Autonomous University of Mexico (UNAM) encourages the use of biotechnology as a tool to solve needs of the Mexican countryside, said Harumi Shimada Beltrn, head of the National Laboratory for Plants under Controlled Conditions (PlanTECC), of the National School of Higher Studies (ENES) Lion.

At PlanTECC, with unique teams in the country, experts perform measurements of the photosynthetic efficiency of the plants; services for your growth; detection of their diseases; characterization of microbial strains; genomic, bioinformatic and molecular biology.

The doctor of science and specialist in plant biotechnology indicated that the above can give us a lot of information about the pathogens and for the genetic improvement of plants

He explained that the laboratory has greenhouses and growth chambers, in which you can carry out controlled, repeatable studies for companies and / or producers.

People associate biotechnology with transgenic plants, but it is much more than that, it is an area that can continue to be promoted in the country to improve agricultural production, he said.

He pointed out that if you understand how genes have an effect on fruit production, you can help change production and if you perceive how a pathogen works, you can expand the tools to control it.

PlanTECC, which began activities in 2016, is an inter-institutional effort between UNAM, the Center for Research and Advanced Studies (Cinvestav) of the National Polytechnic Institute, Irapuato unit, as well as the Center for Research and Assistance in Technology and Design of the State from Jalisco (CIATEJ).

In the laboratory in charge of the UNAM there are eight experts in agrogenomics, who carry out teaching activities in the Bachelor of Agrogenomic Sciences, in the ENES Len, in addition to students of the graduate degree in Biological Sciences and Sustainability Sciences, of the University .

PlanTECC joins efforts of important institutions in agricultural biotechnology to boost producers. It is an area that must be promoted, because if knowledge is provided, the effect will be positive, Shimada concluded.

With information from Lpez-Driga Digital

(function(d, s, id){var js, fjs = d.getElementsByTagName(s)[0];if (d.getElementById(id)) {return;}js = d.createElement(s); js.id = id;js.src="https://connect.facebook.net/es_LA/sdk.js";fjs.parentNode.insertBefore(js, fjs);}(document, 'script', 'facebook-jssdk'));

See the original post:
UNAM contributes to solving the needs of the Mexican countryside with biotechnology - Explica

Biotechnology Market (2019) Report Provides an in-depth summary of Biotechnology Market Status as well as Product Specification, Technology Development, and Key Manufacturers. The Report Gives Detail Analysis on Market concern Like Biotechnology Market share, CAGR Status, Market demand and up to date Market Trends with key Market segments.

The latest report about the Biotechnology market provides a detailed evaluation of the business vertical in question, alongside a brief overview of the industry segments. An exceptionally workable estimation of the present industry scenario has been delivered in the study, and the Biotechnology market size with regards to the revenue and volume have also been mentioned. In general, the research report is a compilation of key data with regards to the competitive landscape of this vertical and the multiple regions where the business has successfully established its position.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2705765&source=atm

Scope of The Biotechnology Market Report:

This research report for Biotechnology Market explores different topics such as product scope, product market by end users or application, product market by region, the market size for the specific product Type, sales and revenue by region forecast the Market size for various segments. The Report provides detailed information regarding the Major factors (drivers, restraints, opportunities, and challenges) influencing the growth of the Biotechnology market. The Biotechnology Market Report analyzes opportunities in the overall Biotechnology market for stakeholders by identifying the high-growth segments.

segment by Type, the product can be split intoDNA SequencingNanobiotechnologyTissue engineering and RegenerationFermentationCell Based AssayPCR TechnologyChromatography MarketOthersMarket segment by Application, split intoHealthFood & AgricultureNatural Resources & EnvironmentIndustrial ProcessingBioinformaticsOthers

Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaJapanSoutheast AsiaIndiaCentral & South America

The study objectives of this report are:To analyze global Biotechnology status, future forecast, growth opportunity, key market and key players.To present the Biotechnology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.To strategically profile the key players and comprehensively analyze their development plan and strategies.To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Biotechnology are as follows:History Year: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Year 2020 to 2026For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2705765&source=atm

A detailed overview of the geographical and competitive sphere of the Biotechnology market:

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2705765&licType=S&source=atm

Table of Content of The Report

Chapter 1- Biotechnology Industry Overview:

1.1 Definition of Biotechnology

1.2 Brief Introduction of Major Classifications

1.3 Brief Introduction of Major Applications

1.4 Brief Introduction of Major Regions

Chapter 2- Production Market Analysis:

2.1 Global Production Market Analysis

2.1.1 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

2.1.2 Major Manufacturers Performance and Market Share

2.2 Regional Production Market Analysis

Chapter 3- Sales Market Analysis:

3.1 Global Sales Market Analysis

3.2 Regional Sales Market Analysis

Chapter 4- Consumption Market Analysis:

4.1 Global Consumption Market Analysis

4.2 Regional Consumption Market Analysis

Chapter 5- Production, Sales and Consumption Market Comparison Analysis

Chapter 6- Major Manufacturers Production and Sales Market Comparison Analysis

Chapter 7- Major Classification Analysis

Chapter 8- Major Application Analysis

Chapter 9- Industry Chain Analysis:

9.1 Up Stream Industries Analysis

9.2 Manufacturing Analysis

Chapter 10- Global and Regional Market Forecast:

10.1 Production Market Forecast

10.2 Sales Market Forecast

10.3 Consumption Market Forecast

Chapter 11- Major Manufacturers Analysis:

11.1.1 Company Introduction

11.1.2 Product Specification and Major Types Analysis

11.1.3 Production Market Performance

11.1.4 Sales Market Performance

11.1.5 Contact Information

11.2.1 Company Introduction

11.2.2 Product Specification and Major Types Analysis

11.2.3 Production Market Performance

11.2.4 Sales Market Performance

11.2.5 Contact Information

Chapter 12- New Project Investment Feasibility Analysis:

12.1 New Project SWOT Analysis

12.2 New Project Investment Feasibility Analysis

Continued

Excerpt from:
Biotechnology Market to Enable the Stakeholders to Capitalize on the Prevailing Industry Opportunities with Investment Analysis By Top Players -...

Global White Biotechnology Market valued approximately USD 248 billion in 2017 is anticipated to grow with a healthy growth rate of more than 10.20% over the forecast period 2018-2025. The White Biotechnology Market is continuously growing in the global scenario at significant pace. The vast environment-related benefits linked with the use of white biotechnology products across a number of application areas has led to the increased focus on the fields development from industries as well as government bodies in the past few years. Most governments have either already allocated or are in the process of allocating substantial budgets for the implementation of white biotechnology technology in the industrial sector

It is our aim to provide our readers with report for White Biotechnology Market, which examines the industry during the period 2020 2026. One goal is to present deeper insight into this line of business in this document. The first part of the report focuses on providing the industry definition for the product or service under focus in the White Biotechnology Market report. Next, the document will study the factors responsible for hindering and enhancing growth in the industry. After covering various areas of interest in the industry, the report aims to provide how the White Biotechnology Market will grow during the forecast period.

The major vendors covered:

Novozymes, Kaneka Corporation, Biosphere, Angel Yeast Co. Ltd., Genecor, DSM, Akzo Nobel, BASF SE, Henkel AG., Du Pont Danisco and more

The final report will add the analysis of the Impact of Covid-19 on White Biotechnology Market.

Request a sample copy @ https://bit.ly/38K414J

The White Biotechnology Market report between the years 2020 2026 will highlight the current value of the industry. At the same time, there is also an estimate of how much this line of business will be worth at the end of the forecast period. As it is our goal to maintain high levels of accuracy at all times, we will take a look at the CAGR of the White Biotechnology Market. We make sure that all the information available in this report has excellent levels of readability. One way we achieve this target is by White Biotechnology Market segmentation. Going through the report for 2020 2026 will bring our readers up-to-date regarding this industry.

While examining the information from this document, one thing becomes clear, the elements which contribute to increase in demand for the product or service. At the same time, there will be a focus on what drives the popularity of these types of products or services. This report is for those who want to learn about White Biotechnology Market, along with its forecast for 2020 2026. Information regarding market revenue, competitive partners, and key players will also be available.

Segmentation

As discussed earlier, there is segmentation in the White Biotechnology Market report, to improve the accuracy and make it easier to collect data. The categories which are the dividing factors in the industry are distribution channels, application, and product or service type. With this level of segmentation, it becomes easier to analyze and understand the White Biotechnology Market. At the same time, there is emphasis on which type of consumers become the customers in this industry. When it comes to distribution channels, the White Biotechnology Market report looks at the different techniques of circulation of the product or service.

Regional Overview

In this part of the White Biotechnology Market report, we will be taking a look at the geographical areas and the role they play in contributing to the growth of this line of business. The areas of interest in this document are as follows Middle East and Africa, South and North America, Europe, and Asia Pacific. From the White Biotechnology Market report, it becomes clear which region is the largest contributor.

Latest Industry News

From this White Biotechnology Market report, the reader will also get to learn about the latest developments in the industry. The reason is that these products or services have the potential to disrupt this line of business. If there is information about company acquisitions or mergers, this information will also be available in this portion of the White Biotechnology Market report.

If you have any special requirements about this White Biotechnology Market report, please let us know and we can provide custom report.

Inquire more about this report @ https://bit.ly/2CtGzfN

About Us

ReportsAndMarkets.com allocates the globally available market research and many company reports from reputed market research companies that are a pioneer in their respective domains. We are completely an autonomous group and serve our clients by offering the trustworthy available research stuff, as we know this is an essential aspect of Market Research.

Contact Us

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

Read more:
IMPACT OF COVID-19 ON White Biotechnology RESEARCH, GROWTH TRENDS AND COMPETITIVE ANALYSIS 2020-2026 - Owned

While discussing about the frontline role of biotechnologists in the COVID-19 research in Bangladesh, Mahmud-Al-Rafat argues about the need of a uniform government policy and recognition for the biotechnologists

WE ARE often saying that the ongoing COVID-19 pandemic has become an eye opener to us but have our eyes really opened? Are we being able to use all our available resources? Though the government is trying to accommodate all expert opinions to fight this war but still some are remain unnoticed. Government cannot fight alone in this pandemic situation, it is also our duty to support the government to make the right decisions and make them accountable for their actions.

This is the right time when we need all hands for not only logistics availability but also we need proper placement of skilled persons. An appropriate utilisation of our human resources is a must to win this war. Here comes both the necessity and negligence towards biotechnologists that remains unnoticed. Being an executive committee member of Bangladesh Association of Biotechnology Graduates, a national platform for biotechnologist, I am privileged to know many untold stories of brave and skilled biotechnologists as well as unfortunate to see how they remain the unsung heroes in this COVID-19 war.

BABG feels the urge to bring these heart touching stories of those young bloods who have sacrificed their personal and family safety in order to support the people in this grave situation. Yes, we are talking about those more than 100 biotechnologists who has served voluntarily in many COVID-19 testing laboratories since March 2020. Some of them are involved in developing laboratory set up and giving training to medical personnel about RT-PCR based test method while some others are involved in doing the test to support increasing governments capacity in COVID-19 management by following test, trace, isolate and support.

Let me share about some brave soul among those front line fighters. Young and energetic biotechnologist Kazi Porag was engaged in developing eight different COVID-19 testing facility since the beginning and now he is a COVID-19 patient himself. Having full knowledge about the life risk during this pandemic, Porag could not resist himself from his duty and responsibility. Being COVID-19 positive is not that much frustrating to him than knowing that after doing all this, still people are saying, this is not the place for biotechnologists, while standing in the lab he developed.

Another skilled biotechnologist, Md Salauddin, is moving across the country since March as a part of his job. His job is to establish RT-PCR labs and train-up people for doing this test. He has been successful to establish so many labs yet has failed to establish the fact that biotechnologists can lead molecular diagnostics.

An inspiring biotechnologist Sabiha Pia started working voluntarily in a lab developed by Salauddin. Dealing with viruses on daily basis, she had to isolate herself from her family members and stay in a small rooftop room. Her family gave her full support but still it was hard for her little boy to support his mom. However the kid is happy now to have his mother back but did Sabiha returned with happy memories? Well, she never had. Because, in this situation, after developing lab, Porag and Salauddin failed to get recognition. BABG talked with many volunteers who were working in many labs across the country. Almost all of them faced negligence and insult while supporting the government fully voluntarily to fight this war. Biotechnology volunteers jumped in this grave situation to support the government without any hesitation and they were prepared to fight COVID-19 but they were not prepared to fight the unwelcomed surroundings. None of them are part of any government support, allowance or any stimulus package even when it comes to get appointed for short period their names come last or even never.

From the beginning BABG was trying to support our government to fight this COVID-19 war by providing volunteers and experts. However, we have noticed that many of our volunteers were hindered to do their job and many of them had to discontinue though these are not by their will. Actually, we have to prepare more volunteers but before that we have to ensure their proper recognition, safety, equal opportunity with other COVID-19 fighters and a friendly environment.

Recently few recruitments and circulars of molecular biologist for testing purpose has drawn attention as they fully ignored biotechnologist. BABG gave a press release by expressing its concern in the recruitment criteria regarding COVID-19 testing facility establishment. This press release was published in many national dailies and also created a noise in social network among biotech graduates. BABG team further met with the directorate general of Health Services authority and expressed the situation faced by our graduates as well as discrimination in recruitment process.

Efforts paid by biotech graduates since March should not go in vain. The DGHS authorities recently issued a letter of recognition to support the voluntary works of biotechnologists and include biotechnology degree as eligibility criteria in a recent temporary recruitment circular for COVID-19 laboratory consultant in Bhola. We are thankful to DGHS, health ministry as well as to authorities who are involved in COVID-19 management but our work is not done yet. It is good that our volunteers works are at least recognised but with this recognition now they should be given equal opportunities to compete and considered in all molecular and medical diagnostics expert position.

As I said earlier, the government alone is not enough to fight this war, BABG wants to provide full support to government in COVID-19 management. UNFPA is working with IEDCR to increase the number of testing throughout the country. BABG had a talk with UNFPA to provide skilled biotechnologist so that testing capacity can be increased.

On the one side, BABG members have to raise their voices to draw attention of authorities so that the authorities can realise that we have enough skilled human resources. And on the other side, BABG has to enlist more volunteers and experts to prepare them to response anytime when they are needed.

University professors from biotechnology departments and BABG executive committee members are writing and talking in both print and electronic media in order to establish the equal right for biotechnologists. BABG already had a discussion with all public university biotechnology department chairman and director general of national institute of biotechnology Md Salimullah.

In that discussion, all agreed that absence of national biotechnology policy is the main reason why biotechnologists are not yet recognised and properly utilised for service. NIB already prepared and submitted a draft of national biotechnology policy but unfortunately due to COVID-19 crisis that policy is yet to be finalised. But, till national biotechnology policy is available, we cannot wait while our graduates are very much capable of doing the test. Moreover, they have the knowledge about how this technology works. Therefore, they involved themselves since the beginning of this crisis. With proper opportunity as well as benefits, we could use more skilled human resources. Besides encouraging and promoting these graduates, BABG is also focusing on developing more skilled volunteers for future. BABG is already planning on-line based training for all biotechnology graduates which will be available across the country.

June 25, 2020 was the 25th anniversary of biotechnology in Bangladesh. This is heart breaking fact that still biotechnologist are not equally treated with other biological graduates for service.

In this COVID-19 situation, now our focus should be how we can engage more of these skilled biotechnologists. We can introduce shifting system in laboratories so that by using the same facility we can increase number of tests. This will involve engagement of few more skilled persons but will not increase extra logistical cost for existing facility.

We should recognise that those biotechnologists who worked in many COVID-19 laboratories are also our frontline fighters like many others in this crisis. If we want to increase our capability we have to promote them as well as engage many more frontline fighters to win against COVID-19.

Mahmud-Al-Rafat is the communication and publication secretary of Bangladesh Association of Biotechnology Graduates

View original post here:
Biotechnologists: the unsung heroes of COVID-19 war in Bangladesh - newagebd.net